AE/1360 / 2024 para aquisição LANREOTIDA 120MG INJ

ID 10893261 · Portal BASE
Price
Base Price
€11,353,500 .00
Effective Price
€113,535 .00 -99.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Company
Dates
Publication
29 Aug 2024
Celebration
16 Apr 2024
Contracting Entity
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE
NIF 506361616
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
86
Supplier
85
Number of Awards
7
Rule
A1 repeat direct award: 7 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
29 Aug 2024
Signing Date
16 Apr 2024
Days Late
135
Rule
A2/A3 late publication: 135 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
11353500.0
Total effective price
113535.0
Ratio
0.01
Direction
reduction
Rule
A9 price reduction: ratio 0.01 outside [0.5, 1.5]
Detected 2026-03-06